Chen Ning, Sun Wei, Deng Xinyu, Hao Yunwei, Chen Xilin, Xing Baocai, Jia Wei, Ma Jie, Wei Handong, Zhu Yunping, Qian Xiaohong, Jiang Ying, He Fuchu
State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, P. R. China.
Proteomics. 2008 Dec;8(23-24):5108-18. doi: 10.1002/pmic.200800280.
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and metastasis is the main cause for treatment failure and high fatality of HCC. In order to make further exploration into the mechanism of HCC metastasis and to search for the candidates of diagnostic marker and therapeutic target, stable-isotope labeling by amino acids in cell culture (SILAC) technique was employed to conduct differential proteome analysis on HCC cell lines--MHCC97L and HCCLM6 with low and high metastatic potentials. In total, 2335 reliable proteins were identified using LTQ-FT mass spectrum, among which 91 proteins were upregulated and 61 proteins were downregulated in HCCLM6. Most of the upregulated proteins were involved in adherence, morphogenesis, and lipid synthesis, while lots of the downregulated proteins were involved in electron transport, which might be crucial for HCC metastasis. Six dysregulated proteins were validated by Western blotting in the cell lines. Interestingly, the upregulation of solute carrier family 12 member 2 (SLC 12A2) and protein disulfide-isomerase A4 (PDIA4) were further confirmed in the culture supernatants by Western blotting and in the sera of HCC patients with different metastatic potentials by ELISA. Our study provided not only the valuable insights into the HCC metastasis mechanisms but also the potential candidate biomarkers for prediction of HCC metastasis.
肝细胞癌(HCC)是全球最常见的癌症之一,转移是导致HCC治疗失败和高死亡率的主要原因。为了进一步探究HCC转移机制并寻找诊断标志物和治疗靶点的候选物,采用细胞培养中氨基酸稳定同位素标记(SILAC)技术,对具有低转移潜能和高转移潜能的HCC细胞系——MHCC97L和HCCLM6进行差异蛋白质组分析。使用LTQ-FT质谱共鉴定出2335种可靠的蛋白质,其中HCCLM6中有91种蛋白质上调,61种蛋白质下调。大多数上调的蛋白质参与黏附、形态发生和脂质合成,而许多下调的蛋白质参与电子传递,这可能对HCC转移至关重要。通过蛋白质免疫印迹法在细胞系中验证了6种失调的蛋白质。有趣的是,通过蛋白质免疫印迹法在培养上清液中以及通过酶联免疫吸附测定法在具有不同转移潜能的HCC患者血清中进一步证实了溶质载体家族12成员2(SLC 12A2)和蛋白二硫键异构酶A4(PDIA4)的上调。我们的研究不仅为HCC转移机制提供了有价值的见解,还为预测HCC转移提供了潜在的候选生物标志物。